SCHEMBL19942011

SCHEMBL19942011

COC(=O)C(C(=O)OC)C1CCCCCCCC1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.62
THRB P10828 1/20 0.59
ALDH1A1 P00352 4/20 0.58
NPSR1 Q6W5P4 2/20 0.58
SMN1; SMN2 Q16637 3/20 0.55
KMT2A Q03164 2/20 0.54
MEN1 O00255 1/20 0.54
TSHR P16473 2/20 0.51
SLC6A3 Q01959 1/20 0.45
EPHX1 P07099 5/20 0.44
EPHX2 P34913 2/20 0.44
NPC1 O15118 1/20 0.44
RAB9A P51151 1/20 0.44
KDM4E B2RXH2 1/20 0.44
CYP3A4 P08684 1/20 0.44
CA12 O43570 2/20 0.44
CA1 P00915 2/20 0.44
CA2 P00918 2/20 0.44
MMP2 P08253 2/20 0.44
CA9 Q16790 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19941727 1.00 TP53 (0.62) TP53THRBALDH1A1NPSR1SMN1; SMN2
SCHEMBL6862095 1.00 TP53 (0.62) TP53THRBALDH1A1NPSR1SMN1; SMN2
SCHEMBL4491334 0.98 THRB (0.61) TP53THRBALDH1A1NPSR1SMN1; SMN2
SCHEMBL27908674 0.93 THRB (0.61) TP53THRBALDH1A1NPSR1SMN1; SMN2
SCHEMBL9488672 0.90 TP53 (0.57) TP53THRBALDH1A1NPSR1SMN1; SMN2
SCHEMBL4970293 0.90 TP53 (0.57) TP53THRBALDH1A1NPSR1SMN1; SMN2
SCHEMBL27926754 0.88 THRB (0.55) TP53THRBALDH1A1NPSR1SMN1; SMN2
SCHEMBL6651323 0.86 TP53 (0.54) TP53THRBALDH1A1NPSR1SMN1; SMN2
SCHEMBL6650169 0.86 TP53 (0.54) TP53THRBALDH1A1NPSR1SMN1; SMN2
SCHEMBL1605366 0.83 TP53 (0.50) TP53THRBALDH1A1NPSR1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018039972-A1 INHIBITORS OF CELLULAR METABOLIC PROCESSES AGIOS PHARMACEUTICALS, INC. (US) 2018-03-08 WO disclosed